Macrophages and bone metastasis

Diletta Di Mitri1,2, Fabio Conforti3, Alberto Mantovani4,5

  • 1Department of Biomedical Sciences, Humanitas University , Pieve Emanuele, Italy.

Insights

Macrophages in prostate cancer bone metastasis create a pathway involving Activin A, extracellular matrix, and SRC kinase. This cascade drives resistance to anti-androgen therapy, impacting hormone and immunity interactions.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Prostate cancer bone metastasis is a complex microenvironment.
  • Therapy resistance is a major clinical challenge in advanced prostate cancer.
  • The interplay between the immune system and cancer cells is crucial for tumor progression.

Purpose of the Study:

  • To elucidate the molecular mechanisms driving resistance to anti-androgen therapy in prostate bone metastasis.
  • To identify key cellular and molecular players within the bone metastasis microenvironment.

Main Methods:

  • Investigated the role of macrophages in the prostate bone metastasis microenvironment.
  • Analyzed the signaling cascade involving Activin A, extracellular matrix, and SRC kinase.
  • Assessed the impact of this cascade on anti-androgen therapy resistance.

Main Results:

  • Macrophages activate a cascade involving Activin A, extracellular matrix, and SRC kinase.
  • This cascade promotes resistance to anti-androgen therapy in prostate cancer bone metastasis.
  • Findings highlight the heterogeneity of metastasis in different tissue environments.

Conclusions:

  • The identified pathway is a critical driver of treatment resistance in prostate cancer bone metastasis.
  • Understanding this interplay between hormones and immunity offers new therapeutic targets.
  • Metastasis diversity is influenced by tissue-specific microenvironmental factors.